Schuringa JJ - Search Results

1

Cancer stem cell definitions and terminology: the devil is in the details.

Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, Chomienne C, Ishikawa F, Schuringa JJ, Stassi G, Huntly B, Herrmann H, Soulier J, Roesch A, Schuurhuis GJ, Wöhrer S, Arock M, Zuber J, Cerny-Reiterer S, Johnsen HE, Andreeff M, Eaves C. Valent P, et al. Among authors: schuringa jj. Nat Rev Cancer. 2012 Nov;12(11):767-75. doi: 10.1038/nrc3368. Epub 2012 Oct 11. Nat Rev Cancer. 2012. PMID: 23051844 Review.

2

Genetic and epigenetic alterations that drive leukemic stem cell self-renewal.

van den Boom V, Horton SJ, Schuringa JJ. van den Boom V, et al. Among authors: schuringa jj. J Stem Cells. 2012;7(3):155-79. J Stem Cells. 2012. PMID: 23619382 Review.

3

Apoptosis and cancer stem cells: Implications for apoptosis targeted therapy.

Kruyt FA, Schuringa JJ. Kruyt FA, et al. Among authors: schuringa jj. Biochem Pharmacol. 2010 Aug 15;80(4):423-30. doi: 10.1016/j.bcp.2010.04.010. Epub 2010 Apr 13. Biochem Pharmacol. 2010. PMID: 20394737

4

MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.

Horton SJ, Jaques J, Woolthuis C, van Dijk J, Mesuraca M, Huls G, Morrone G, Vellenga E, Schuringa JJ. Horton SJ, et al. Among authors: schuringa jj. Leukemia. 2013 Apr;27(5):1116-26. doi: 10.1038/leu.2012.343. Epub 2012 Nov 26. Leukemia. 2013. PMID: 23178754

5

Ex vivo assays to study self-renewal, long-term expansion, and leukemic transformation of genetically modified human hematopoietic and patient-derived leukemic stem cells.

Sontakke P, Carretta M, Capala M, Schepers H, Schuringa JJ. Sontakke P, et al. Among authors: schuringa jj. Methods Mol Biol. 2014;1185:195-210. doi: 10.1007/978-1-4939-1133-2_13. Methods Mol Biol. 2014. PMID: 25062630

6

Single-cell STAT5 signal transduction profiling in normal and leukemic stem and progenitor cell populations reveals highly distinct cytokine responses.

Han L, Wierenga AT, Rozenveld-Geugien M, van de Lande K, Vellenga E, Schuringa JJ. Han L, et al. Among authors: schuringa jj. PLoS One. 2009 Nov 24;4(11):e7989. doi: 10.1371/journal.pone.0007989. PLoS One. 2009. PMID: 19956772 Free PMC article.

7

BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.

Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, van den Boom V, Vellenga E, de Haan G, Schuringa JJ. Rizo A, et al. Among authors: schuringa jj. Blood. 2010 Nov 25;116(22):4621-30. doi: 10.1182/blood-2010-02-270660. Epub 2010 Aug 19. Blood. 2010. PMID: 20724541 Free article.

8

Establishing long-term cultures with self-renewing acute myeloid leukemia stem/progenitor cells.

van Gosliga D, Schepers H, Rizo A, van der Kolk D, Vellenga E, Schuringa JJ. van Gosliga D, et al. Among authors: schuringa jj. Exp Hematol. 2007 Oct;35(10):1538-49. doi: 10.1016/j.exphem.2007.07.001. Exp Hematol. 2007. PMID: 17889721 Free article.

9

Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.

Fatrai S, Schepers H, Tadema H, Vellenga E, Daenen SM, Schuringa JJ. Fatrai S, et al. Among authors: schuringa jj. Exp Hematol. 2008 Oct;36(10):1254-65. doi: 10.1016/j.exphem.2008.04.015. Epub 2008 Jul 21. Exp Hematol. 2008. PMID: 18640764 Free article.

10

KRAS(G12V) enhances proliferation and initiates myelomonocytic differentiation in human stem/progenitor cells via intrinsic and extrinsic pathways.

Fatrai S, van Gosliga D, Han L, Daenen SM, Vellenga E, Schuringa JJ. Fatrai S, et al. Among authors: schuringa jj. J Biol Chem. 2011 Feb 25;286(8):6061-70. doi: 10.1074/jbc.M110.201848. Epub 2010 Dec 17. J Biol Chem. 2011. PMID: 21169357 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page